Yasemin Başpınar

11PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 14, 2026
DDR2-COL11A1 Transcriptional Coupling as a Candidate Therapeutic Target in Colorectal Cancer: Integrative Transcriptomic and Deep Learning Validation.

Yasemin Başbınar, Ömer Akgüller, Asım Leblebici

|Nov 21, 2025
Inhibition of FXa could be a novel therapeutic target associated with hypoxia-associated tumor behavior?

Ozge Bayrak, Nazlı Mert, Yasemin Basbinar

|Oct 08, 2025
Epigenetic potentiation of 5-fluorouracil by HDAC inhibitor quisinostat enhances antitumor effects in colorectal cancer.

Gizem Calibasi-Kocal, Hasan Kurter, Eylem Doga Nartas

|Apr 01, 2024
In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens.

Aras Emre Canda, Tolga Sever, Gizem Calibasi Kocal

|Dec 28, 2023
High and low dietary fiber consumption and cancer risk: a comprehensive umbrella review with meta-meta-analysis involving meta-analyses of observational epidemiological studies.

Mehmet Emin Arayici, Yasemin Basbinar, Hulya Ellidokuz

|Oct 07, 2022
The impact of cancer on the severity of disease in patients affected with COVID-19: an umbrella review and meta-meta-analysis of systematic reviews and meta-analyses involving 1,064,476 participants.

Mehmet Emin Arayici, Yasemin Basbinar, Hulya Ellidokuz

Pageof 2

Frequent Collaborators

7 joint publications

Hulya Ellidokuz

3 joint publications

Nazlı Mert

3 joint publications

Gizem Çalıbaşı Koçal

3 joint publications

Mehmet Emin Arayici